metastatic castration resistant prostate cancer (mcrpc)
Showing 1 - 8 of 8
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,
Terminated
- Non-small Cell Lung Cancer (NSCLC)
- +6 more
- NZV930
- +2 more
-
Tampa, Florida
- +9 more
Nov 2, 2022
Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial (Pidnarulex, Talazoparib)
Not yet recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- (no location specified)
Jun 15, 2022
Patients and Other Factors Which May Contribute to Survival
Completed
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Radium-223 dichloride (Xofigo, BAY88-8223)
-
Whippany, New JerseyBayer Flatiron Xofigo Registry database
Mar 17, 2022
Prostate Cancer Patients Treated With Lutetium - Prostate
Recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- WB-MRI
-
Meldola, Forlì-Cesena, Italy
- +1 more
Jan 12, 2022
Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- avelumab
- +3 more
-
Rochester, New York
- +4 more
Sep 17, 2021
Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Sydney, Melbourne (Olaparib, 177Lu-PSMA)
Recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Olaparib
- 177Lu-PSMA
-
Sydney, New South Wales, Australia
- +1 more
Jun 12, 2020
Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Chapel Hill (Exercise)
Withdrawn
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Exercise
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Feb 10, 2016